Neuropsychiatric symptoms in alzheime disease and related disorders: Why do treatments work in clinical practice but not in the randomized trials?

American Journal of Geriatric Psychiatry

Volumn 16, Issue 7, 2008, Pages 523-527

  Lavretsky, Helen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CHOLINESTERASE INHIBITOR; CITALOPRAM; MEMANTINE; METHYLPHENIDATE; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; TRAZODONE; VALPROIC ACID;

AGED; AGITATION; ALZHEIMER DISEASE; ANTICHOLINERGIC EFFECT; APATHY; BEHAVIOR THERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; DEMENTIA; DEPRESSION; DRUG EFFICACY; DRUG WITHDRAWAL; EDITORIAL; EXTRAPYRAMIDAL SYMPTOM; GERONTOPSYCHIATRY; HUMAN; MENTAL DISEASE; MENTAL PATIENT; METABOLIC DISORDER; METABOLIC SYNDROME X; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; TARDIVE DYSKINESIA; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; BEHAVIOR; EVIDENCE BASED MEDICINE; TREATMENT OUTCOME;

AGED; ALZHEIMER DISEASE; BEHAVIORAL SYMPTOMS; DEMENTIA; EVIDENCE-BASED MEDICINE; HUMANS; PSYCHOTROPIC DRUGS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 50349083920     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e318178416c     Document Type: Editorial

References (42)

1. Ferri CP, Prince M, Brayne C, et al: Alzheimer's Disease International Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366:2112-2117
2. Lyketsos CG, Steinberg M, Tschanz JT, et al: Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry 2000; 157:708-714
3. Matsui T, Nakaaki S, Murata Y, et al: Determinants of the quality of life in Alzheimer's disease patients as assessed by the Japanese version of the Quality of Life-Alzheimer's disease scale. Dement Geriatr Cogn Disord 2006; 21:182-191
4. Jeste DV, Blazer D, Casey D, et al: ACNP white paper: update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology 2008; 33:957-970
5. Cummings JL: Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis. Neurobiol Aging 2000; 21:845-861
6. Tractenberg RE, Weiner MF, Patterson MB, et al: Comorbidity of psychopathological domains in community-dwelling persons with Alzheimer's Disease. J Geriatr Psychiatry 2003; 16:94-99
7. Ryu SH, Katona C, Rive B, et al: Persistence of and changes in neuropsychiatric symptoms in Alzheimer disease over 6 months: the LASER-AD study. Am J Geriatr Psychiatry 2005; 13:976-983
8. Ballard C: Agitation and psychosis in dementia. Am J Geriatr Psychiatry 2007; 15:913-917
9. Mizrahi R, Starkstein SE: Epidemiology and management of apathy in patients with Alzheimer's disease. Drugs Aging 2007; 24: 547-554
10. Starkstein SE: Apathy and withdrawal. Int Psychogeriatr 2000; 12:135-137
11. Lavretsky H, Ballmaier M, Pham D, et al: Neuroanatomical characteristics of geriatric apathy and depression: a magnetic resonance imaging study. Am J Geriatr Psychiatry 2007; 15:386-394
12. Schneider LS, Dagerman K, Insel PS: Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 2006; 14:191-210
13. Glazer WM: Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality. J Clin Psychiatry 2000; 61:16-21
14. Jeste DV, Lacro JP, Bailey A, et al: Incidence of tardive dyskinesia with risperidone versus haloperidol. J Am Geriatr Society 1999; 47:716-719
15. Jin H, Meyer JM, Jeste DV: Atypical antipsychotics and glucose dysregulation: a systematic review. Schizophr Res 2004; 71:195-212
16. Ballard C, Waite J: The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Syst Rev 2006; 1: CD003476
17. Sink KM, Holden KF, Yaffe K: Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. J Am Med Assoc 2005; 293:596-608
18. Schneider LS, Tariot PN, Dagerman KS, et al: Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med 2006; 355:1525-1538
19. Sultzer D, Lavretsky H: Antipsychotic medications in the elderly, in Kaplan sb & Sadock's Comprehensive Textbook of Psychiatry. Edited by Sadock B, Sadock V. Philadelphia, PA, Lippincott Williams & Wilkins, 1999, pp 3096-3100
20. Gauthier S, Loft H, Cummings J: Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis. Int J Geriatr Psychiatry 2008; 23:537-45
21. Cummings JL, McRae T, Zhang R, et al: Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders. Am J Geriatr Psychiatry 2006; 14:605-612
22. Cummings JL, Schneider E, Tariot PN, et al: Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment. Neurology 2006; 67:57-63
23. Tariot PN: Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies. J Clin Psychiatry 2006; 67:15-22
24. Trinh NH, Hoblyn J, Mohanty S: Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. J Am Med Assoc 2003; 289:210-216
25. Sultzer DL, Gray KF, Gunay I: Does behavioral improvement with haloperidol or trazodone treatment depend on psychosis or mood symptoms in patients with dementia? J Am Geriatr Soc 2001; 49:1294-1300
26. Tariot PN, Raman R, Jakimovich L, et al: Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial. Am J Geriatr Psychiatry 2005; 13:942-949
27. Porsteinsson AP: Divalproex sodium for the treatment of behavioural problems associated with dementia in the elderly. Drugs Aging 2006; 23:877-886
28. Lonergan ET, Cameron M, Luxenberg J: Valproic acid for agitation in dementia. Cochrane Database Syst Rev 2004; 2:CD003945
29. Roth RM, Flashman LA, McAllister TW: Apathy and its treatment. Curr Treat Options Neurol 2007; 9:363-370
30. Lavretsky H: Therapy of depression in dementia. Expert Rev Neurotherpautics 2003; 3:89-97
31. Lavretsky H, Kumar A: Clinically significant non-major depression: old concepts, new insights. Am J Geriatr Psychiatry 2002; 10:239-255
32. Teri L, Logsdon RG, Peskind E, et al: Treatment of agitation in AD: a randomized, placebo-controlled clinical trial. Neurology 2000; 55:1271-1278.
33. Erratum, Neurology 2001; 56:426
34. Gitlin LN, Winter L, Burke J, et al: Tailored activities to manage neuropsychiatric behaviors in persons with dementia and reduce caregiver burden: a randomized pilot study. Am J Geriatr Psychiatry 2008; 16:229-239
35. Cohen-Mansfield J, Libin A, Marx MS: Nonpharmacological treatment of agitation: a controlled trial of systematic individualized intervention. J Gerontol A Biol Sci Med Sci 2007; 62:908-916
36. Davison TE, Hudgson C, McCabe MP, et al: An individualized psychosocial approach for "treatment resistant" behavioral symptoms of dementia among aged care residents. Int Psychogeriatr 2007; 19:859-873
37. Selbaek G, Qyvind K, Knut E: The course of psychiatric and behavioral symptoms and the use of psychotropic medications in patients with dementia in Norwegian nursing homes: a 12 month follow-up study. Am J Geriatr Psychiatry 2008; 16:528-536
38. Streim JE, Porsteinsson AP, Breder CD, et al: A randomized double-blind placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer's disease. Am J Geriatr Psychiatry 2008; 16:537-550
39. Lanctot KL, Herrmann N, Black SE, et al: Apathy associated with Alzheimer's disease: use of dextramphetamine challenge. Am J Geriatr Psychiatry 2008; 16:551-557
40. Cummings JL, Jeste DV: Pharmacotherapy of neuropsychiatric syndromes in neurologic disorders: definitional and regulatory aspects. Psychopharmacol Bull 2007; 40:89-98
41. Tune LE: Nonpharmacologcial treatment of inappropriate sexual behavior in dementia: the case of the Pink Panther. Am J Geriatr Psychiatry 2008; 16:612-616
42. Zerhouni EA: Translational research: moving discovery to practice. Clin Pharmacol Therapeutics 2007; 81:126-28